Fosamax Patient Assistance for Low-Income: How to Get Alendronate Free or Cheap in 2026

Why Alendronate Cost Matters for Osteoporosis Treatment

Osteoporosis affects an estimated 10.2 million Americans aged 50 and older, with another 43.4 million having low bone mass, according to data from the National Osteoporosis Foundation cited by the CDC [1]. Treatment gaps driven by cost are a documented clinical problem. A 2019 analysis in the Journal of Bone and Mineral Research found that cost-related non-adherence to oral bisphosphonates was associated with a 21% higher fracture risk over three years [2].

Alendronate (brand name Fosamax) is a first-line bisphosphonate therapy backed by the American College of Physicians' 2017 clinical guideline, which states: "ACP recommends that clinicians use bisphosphonates as first-line pharmacologic therapy for women with primary osteoporosis." [3] The drug has been off-patent since 2008, which means the generic is chemically identical to brand Fosamax and costs a fraction of the price.

What Clinical Evidence Supports Alendronate

The Fracture Intervention Trial (FIT), which enrolled 2,027 postmenopausal women with low bone density and at least one vertebral fracture, showed that alendronate reduced the risk of new vertebral fractures by 47% and hip fractures by 51% over three years compared to placebo (P<0.001) [4]. The FDA approved alendronate for postmenopausal osteoporosis prevention and treatment, for glucocorticoid-induced osteoporosis, and for Paget's disease of bone [5].

Generic vs. Brand: Is There a Clinical Difference

No. The FDA's Orange Book confirms that all AB-rated generic versions of alendronate sodium 70 mg tablets are therapeutically equivalent to Fosamax [5]. Switching from brand to generic does not require a dose adjustment and produces the same bone mineral density outcomes in head-to-head bioequivalence studies [6].

The Real Cash Price of Generic Alendronate in 2026

Generic alendronate 70 mg (one tablet per week, 4 tablets per month) is one of the cheapest prescription drugs in the United States. Cash-pay prices range from $4 to $15 per month depending on the pharmacy, and no insurance or assistance program is needed to access the lowest tiers.

Pharmacy-by-Pharmacy Price Comparison

| Pharmacy | Cash Price (70 mg x 4 tablets) | Notes | |---|---|---| | Walmart $4 generic list | $4/month | No membership required | | Mark Cuban's Cost Plus Drugs | $4.80/month | costplusdrugs.com, ships nationwide | | Costco Pharmacy | $6, $9/month | Open to non-members for prescriptions | | Kroger/Fry's | $10, $12/month | Varies by region | | CVS / Walgreens (with GoodRx) | $4, $9/month | Requires free GoodRx card or app | | Rite Aid (with GoodRx) | $5, $10/month | |

The Cost Plus Drugs platform, launched in 2022, publishes a transparent cost-plus-15% pricing model. Their alendronate price of approximately $4.80 per month is publicly listed and does not require insurance [7].

When Cash Price Is Still a Barrier

For patients on fixed incomes where even $5 per month is difficult, the programs below reduce cost to zero.

Merck Patient Assistance Program for Brand Fosamax

Merck, the original manufacturer of Fosamax, operates a patient assistance program through the Merck Patient Assistance Program (MPAP). The program provides free brand-name Fosamax to uninsured and underinsured patients who meet financial eligibility criteria.

Who Qualifies

Eligibility requirements change periodically. As of early 2026, the general criteria include:

• United States resident with a valid prescription from a licensed U.S. Prescriber
• No prescription drug insurance coverage, or coverage with a gap that makes the drug unaffordable
• Household income at or below approximately 200% to 400% of the Federal Poverty Level (FPL). The 2025 FPL for a family of four is $32,150, making the upper income threshold approximately $64,300 to $128,600 [8].

Merck notes on its program page that thresholds and program details change. Patients should verify current criteria directly at merck.com/patient-assistance or by calling 1-800-727-5400.

How to Apply

1. Ask your prescriber to complete the physician section of the MPAP application form.
2. Submit proof of income (tax return, pay stubs, or Social Security award letter).
3. Submit proof of insurance status (denial letter or insurance card showing no drug benefit).
4. Mail or fax the completed packet. Processing takes approximately 2 to 4 weeks.
5. Approved patients receive a 90-day supply mailed to the prescriber's office, renewable quarterly.

A Note on Generic vs. Brand Through MPAP

Because generic alendronate is already so inexpensive ($4 to $15), most assistance programs focus on brand Fosamax or on patients who have specific insurance coverage issues. If a patient qualifies for Walmart's $4 program or Cost Plus Drugs, pursuing the Merck PAP may not be the most time-efficient path.

GoodRx, NeedyMeds, and Third-Party Discount Cards

Discount card programs are not insurance. They are negotiated pricing agreements between pharmacy benefit managers and pharmacies. No application or income verification is required.

GoodRx

GoodRx is free to use. A patient presents the GoodRx card or shows the app coupon at the pharmacy counter. For alendronate 70 mg (4 tablets), GoodRx prices range from $4 to $9 at CVS, Walgreens, Rite Aid, and Kroger as of January 2026 [9]. GoodRx cannot be combined with insurance at the same transaction; it is used instead of insurance when the discount price is lower than the insurance copay.

NeedyMeds

NeedyMeds (needymeds.org) maintains a database of more than 2,000 patient assistance programs, including state-run programs that cover osteoporosis medications. Their drug search tool lists current alendronate assistance options by state. NeedyMeds also provides a free Drug Discount Card that typically prices generic alendronate at $4 to $8 [10].

RxAssist

RxAssist (rxassist.org) is a physician-facing and patient-facing database of manufacturer PAPs maintained with support from AstraZeneca and other funders. It cross-references all current Merck programs and provides direct application links [11].

Medicare Part D and Extra Help for Alendronate

For patients aged 65 and older, or those under 65 with qualifying disabilities, Medicare Part D covers generic alendronate. The drug appears on Tier 1 (preferred generic) on most Part D formularies, with copays ranging from $0 to $10 per month depending on the plan [12].

Medicare Extra Help (Low Income Subsidy)

The Social Security Administration's Extra Help program, also called the Low Income Subsidy (LIS), reduces Part D premiums and copays for beneficiaries with limited income and resources. In 2025, beneficiaries who receive full Extra Help pay no more than $11.20 for each covered drug or $4.50 for generics [13]. Alendronate, as a Tier 1 generic, typically falls in the $4.50 copay category.

To qualify for Extra Help in 2026:

• Individual income must be at or below $23,340 (150% of FPL for a single person).
• Resources must be at or below $17,220 for an individual [13].

Applications are submitted through the Social Security Administration at ssa.gov/extrahelp or by calling 1-800-772-1213.

Medicare Advantage Plans

Many Medicare Advantage (Part C) plans include Part D drug benefits with $0 copays for Tier 1 generics. Patients should use Medicare's Plan Finder at medicare.gov to compare formularies. A 2022 analysis published in Health Affairs found that 68% of Medicare Advantage enrollees had access to Tier 1 generics with $0 copay in the coverage gap [14].

Medicaid Coverage for Alendronate

Medicaid covers alendronate in all 50 states. Because the drug is a low-cost generic and meets the criteria for a preferred first-line osteoporosis therapy, state Medicaid formularies consistently include it. Copays range from $0 to $3 depending on the state and the beneficiary's income level [15].

Medicaid Expansion and Eligibility

Under the Affordable Care Act's Medicaid expansion (adopted by 40 states and Washington, D.C. As of 2026), adults with incomes at or below 138% of FPL qualify for Medicaid. For a single adult in 2025, that threshold is approximately $20,783 per year [8]. Patients who qualify for Medicaid will generally receive alendronate at no cost.

Dual Eligibles

Patients enrolled in both Medicare and Medicaid (dual eligibles) automatically qualify for Medicare Extra Help and typically pay $0 to $4.50 for alendronate under the Medicare Part D benefit [13].

State Pharmaceutical Assistance Programs (SPAPs)

Thirty-eight states operate their own pharmaceutical assistance programs that supplement Medicare Part D or provide standalone drug coverage for low-income residents not eligible for Medicaid. Examples include:

• PACE/PACENET (Pennsylvania): Covers generic alendronate at a $6 copay for single enrollees earning up to $33,500 per year.
• EPIC (New York): Covers alendronate with copays calculated on a sliding scale based on income.
• PAAD (New Jersey): Provides copay assistance for residents earning up to 250% of FPL.

The National Conference of State Legislatures maintains a regularly updated directory of SPAPs at ncsl.org [16]. Patients should verify that their state's program is currently accepting applications, as funding and enrollment periods vary.

Osteoporosis Foundation and Nonprofit Resources

The National Osteoporosis Foundation (NOF), now operating under the Bone Health and Osteoporosis Foundation (BHOF) name, provides a resource guide for patients struggling with medication costs at bonehealthandosteoporosis.org [17]. Their pharmacist helpline (1-800-231-4222) can assist patients in identifying the lowest-cost option for their specific insurance situation.

Partnership for Prescription Assistance (PPA)

The PPA program at pparx.org aggregates more than 475 manufacturer and nonprofit assistance programs into a single search tool. Patients enter their drug name, income, and insurance status and receive a ranked list of applicable programs [18].

Fosamax Insurance Coverage: What to Do When Your Plan Denies It

Some commercial insurance plans place alendronate on a higher tier or require step therapy through a lower-cost option before covering it. This is uncommon given the drug's generic availability, but it does occur.

Step Therapy and Prior Authorization

If your insurer requires prior authorization for alendronate, your prescriber can submit documentation of your osteoporosis diagnosis (bone density T-score, fracture history) and clinical indication. The American Society for Bone and Mineral Research has published position statements supporting bisphosphonate access as first-line therapy [19], which prescribers can reference in PA letters.

Appealing a Denial

Under the No Surprises Act and existing ACA provisions, patients have the right to appeal insurance coverage denials. A formal internal appeal followed by an external review can take 30 to 60 days but succeeds in a meaningful proportion of cases when clinical documentation is complete [20].

Using a Discount Card While Appealing

During an insurance appeal, patients can use GoodRx or Cost Plus Drugs to obtain generic alendronate at $4 to $10 per month rather than interrupting therapy. Discontinuing bisphosphonate therapy increases fracture risk; the FIT trial showed that the bone-protective effect begins to diminish within 12 months of stopping treatment [4].

How to Talk to Your Doctor About Cost

Many patients do not mention medication cost to their prescriber, and prescribers often do not ask. A 2021 survey published in JAMA Internal Medicine found that only 29% of physicians routinely discussed out-of-pocket drug costs with patients, despite cost being the leading reason for non-adherence [21].

Script for the Appointment

Tell your prescriber: "I want to stay on this medication, but the cost is a barrier. Can we use generic alendronate, and can your office help me apply for patient assistance?" Most practices have a social worker or care coordinator who manages PAP applications.

The HealthRX Access Framework for alendronate cost reduction uses a three-step triage:

1. Check cash price first. If generic alendronate is $4 to $15 at a nearby pharmacy, assistance programs may be unnecessary overhead.
2. Layer a discount card. If cash price exceeds $15, apply a GoodRx or NeedyMeds card before any formal application process.
3. Apply for a structured program only if steps 1 and 2 leave a remaining barrier. At that point, match the patient to Medicare Extra Help, Medicaid, SPAP, or Merck PAP based on age and income.

This approach reduces the average time-to-access from 3 to 4 weeks (typical for PAP applications) to same-day for most patients.

Alendronate Dosing: Confirming You Have the Right Prescription

Before spending time on cost-access programs, confirm that your prescription reflects current clinical guidelines. The standard dosing approved by the FDA for postmenopausal osteoporosis is 70 mg orally once weekly [5]. A once-weekly regimen means one tablet per week and roughly four tablets per month, which is the quantity priced at $4 to $15 at low-cost pharmacies.

Once-Weekly vs. Once-Daily

The once-daily 10 mg formulation is therapeutically equivalent to the once-weekly 70 mg tablet per the FDA label and the 2022 American Association of Clinical Endocrinologists (AACE) clinical practice guidelines on osteoporosis [22]. Once-weekly dosing is preferred for adherence. A 2003 study in Osteoporosis International (N=1,053) found that patients on once-weekly alendronate had a 72% one-year adherence rate vs. 58% for once-daily dosing (P<0.01) [23].

Duration of Therapy

The AACE 2022 guidelines recommend a treatment duration of 3 to 5 years for most patients, followed by a reassessment that may include a drug holiday for lower-risk patients [22]. This means the total lifetime cost of generic alendronate at $4 to $15 per month is $144 to $900 over a 3-year course, which is low compared to injectable alternatives like denosumab (Prolia, approximately $1,800 per year) or zoledronic acid (Reclast, approximately $1,200 per infusion) [24].

Comparing Alendronate to Alternative Osteoporosis Drugs on Cost

If a patient truly cannot access alendronate through any pathway above, the prescriber may consider alternatives. The cost and access field for osteoporosis medications varies considerably:

| Drug | Route | Frequency | Estimated Annual Cash Cost | |---|---|---|---| | Alendronate (generic) | Oral | Weekly | $48, $180 | | Risedronate (generic) | Oral | Weekly | $80, $240 | | Ibandronate (generic) | Oral | Monthly | $20, $60 | | Zoledronic acid (generic) | IV infusion | Yearly | $200, $600 (drug only) | | Denosumab (Prolia, brand only) | Subcutaneous | Every 6 months | $1,600, $2,200 | | Raloxifene (generic) | Oral | Daily | $30, $90 |

Data sourced from Cost Plus Drugs, GoodRx, and FDA Orange Book listings as of January 2026 [5][7][9]. Zoledronic acid's cost advantage is offset by infusion administration fees.

Frequently Asked Questions